STOCK TITAN

Chemours Co (NYSE: CC) CEO records 477-share tax withholding

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Chemours Co director and Chief Executive Officer Denise Dignam reported a tax-withholding disposition of 477 shares of common stock on August 1, 2026 at $16.61 per share. Shares were automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units; no shares were sold. Following this withholding, she reported 337,492.9016 shares held directly, including restricted stock units and dividend equivalent units.

Positive

  • None.

Negative

  • None.
Insider Dignam Denise
Role Chief Executive Officer
Type Security Shares Price Value
Tax Withholding Common Stock F1, F2 477 $16.61 $8K
Holdings After Transaction: Common Stock — 337,492.9016 shares (Direct)
Footnotes (2)
  1. F1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
  2. F2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Shares withheld for taxes 477 shares Tax-withholding disposition on 2026-08-01 for vesting equity awards
Price per withheld share $16.61 Per-share value used to satisfy tax obligations on withheld shares
Shares following transaction 337,492.9016 shares Total direct holdings after tax withholding, including RSUs and dividend equivalents
restricted stock units financial
"Shares automatically withheld to satisfy tax obligations on vesting restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent units financial
"vesting restricted stock units and dividend equivalent units. Transactions are exempt"
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
Section 16(b) regulatory
"Transactions are exempt from Section 16(b) pursuant to Rule 16b-3."
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3 regulatory
"exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold."
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Chemours (CC) CEO Denise Dignam report?

Denise Dignam reported a tax-withholding disposition of 477 shares of Chemours common stock. The shares were automatically withheld to cover taxes on vesting restricted stock units and dividend equivalent units, and no shares were sold in the market.

Was the Chemours (CC) CEO’s Form 4 transaction an open-market sale?

No. The Form 4 states that no shares were sold. Instead, 477 shares were automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units, a transaction type described as a tax-withholding disposition.

How many Chemours (CC) shares were withheld for the CEO’s taxes?

The filing reports that 477 shares of Chemours common stock were automatically withheld. These shares covered tax obligations arising from the vesting of restricted stock units and related dividend equivalent units, using a value of $16.61 per share for the withholding.

What was the reported value per share for the Chemours (CC) CEO’s withheld stock?

The withheld shares were valued at $16.61 per share for tax purposes. This per-share amount was used to determine the value of the 477 shares automatically withheld to satisfy the CEO’s tax obligations on vesting equity awards.

How many Chemours (CC) shares does the CEO hold after this Form 4 transaction?

After the tax-withholding transaction, Denise Dignam reported 337,492.9016 shares held directly. A footnote explains this figure includes directly owned shares, restricted stock units, and dividend equivalent units associated with her Chemours equity awards.

Does the Chemours (CC) CEO’s Form 4 mention Rule 16b-3 treatment?

Yes. A footnote states the tax-withholding transactions are exempt from Section 16(b) pursuant to Rule 16b-3. This exemption applies because the shares were automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dignam Denise

(Last)(First)(Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET

(Street)
WILMINGTON DELAWARE 19801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/01/2026F(1)477(2)D$16.61337,492.9016D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. Includes directly owned shares, restricted stock units and dividend equivalent units.
/s/ Eric Stein, Attorney-in-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)